LOADING
Comparing Merck & Company (MRK) and Snap Inc (SNAP) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | SNAP |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $356.0B | $9.6B |
| P/E Ratio | 116.4 | -- |
| Forward P/E | 15.3 | 7.7 |
| PEG Ratio | 2.71 | 496.06 |
| EPS | $1.24 | $-0.18 |
| Revenue Growth (YoY) | 5.1% | 18.9% |
| Profit Margin | 4.8% | -4.9% |
| Return on Equity | 7.0% | -15.6% |
| Dividend Yield | 2.31% | -- |
| Beta | 0.23 | 1.05 |
| 52-Week High | $156.00 | $9.13 |
| 52-Week Low | $79.67 | $3.81 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.